|
|
American
Physiological Society Publications Policy on the Publication of Research on
Human Fetuses, Fetal Tissue, Embryos, and Embryonic Cells
The research described in papers
submitted to any of the APS publications that involve the use of human fetuses,
fetal tissue, embryos, or embryonic cells must adhere to U.S. Public Law 103-43,
Section 498B(a) and Title 45, U.S. Code of Federal Regulations, Part 46,
Protection of Human Subjects, Revised November 13, 2001, effective December 13,
2001, Department of Health and Human Services, National Institutes of Health,
Office for the Protection from Research Risks, unless regulated by more
restrictive state or local laws. In addition, the study must meet all these
criteria:
The researcher may not be involved
in any decisions as to the timing, method, and procedures used to terminate
the pregnancy or determining the viability of the fetus at the termination
of the pregnancy. Inducements, monetary or otherwise, may not have been
offered to terminate pregnancy and valid informed consent must have been
obtained from the donor. Vital functions of the fetus cannot
be artificially maintained and the heartbeat or respiration of the fetus
cannot be terminated as part of an experiment. Activities involving a dead fetus,
macerated fetal material, or cells, tissue, or organs excised from a dead
fetus shall be conducted only in accordance with any applicable state or
local laws regarding such activities. The acquisition of embryonic cells
from in vitro fertilization must adhere to any applicable state or local
laws. Authors must state in the
methodology section of the paper that the study received approval from the
IRB or equivalent ethical review body. Authors must also state how and from
where the tissue or cells were obtained.
|
|
